154 related articles for article (PubMed ID: 38129673)
1. The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12.
Sun Y; Liu Y; Wang P; Chang L; Huang J
Mol Biotechnol; 2024 May; 66(5):1051-1061. PubMed ID: 38129673
[TBL] [Abstract][Full Text] [Related]
2. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.
Xu D; Wang Z; Li F
Crit Rev Immunol; 2024; 44(6):49-61. PubMed ID: 38848293
[TBL] [Abstract][Full Text] [Related]
3. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of m
Wang J; Tan L; Jia B; Yu X; Yao R; OUYang N; Yu X; Cao X; Tong J; Chen T; Chen R; Li J
Int J Biol Sci; 2021; 17(10):2633-2651. PubMed ID: 34326699
[TBL] [Abstract][Full Text] [Related]
5. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
6. The m
Ma L; Chen T; Zhang X; Miao Y; Tian X; Yu K; Xu X; Niu Y; Guo S; Zhang C; Qiu S; Qiao Y; Fang W; Du L; Yu Y; Wang J
Redox Biol; 2021 Jan; 38():101801. PubMed ID: 33232910
[TBL] [Abstract][Full Text] [Related]
7. [LIM-domain binding protein 2 regulated by m
Zhai D; Wang G; Li L; Jia X; Zheng G; Yin J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):329-335. PubMed ID: 33849822
[TBL] [Abstract][Full Text] [Related]
8. lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m
Wang J; Tan L; Yu X; Cao X; Jia B; Chen R; Li J
Mol Cancer; 2022 Dec; 21(1):229. PubMed ID: 36581942
[TBL] [Abstract][Full Text] [Related]
9.
Wang X; Hu Y; Li X; Zhu C; Chen F
J Thorac Dis; 2023 Mar; 15(3):1247-1257. PubMed ID: 37065597
[TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
Hu Z; Zhu L; Zhang Y; Chen B
Bioengineered; 2022 Feb; 13(2):3093-3107. PubMed ID: 35068325
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
Teng Y; Zhao X; Xi Y; Fu N
Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of m
Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
[TBL] [Abstract][Full Text] [Related]
14. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC
Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429
[TBL] [Abstract][Full Text] [Related]
15. METTL3-mediated m
Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
[TBL] [Abstract][Full Text] [Related]
16. The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases.
Wu X; Chen H; Li K; Zhang H; Li K; Tan H
J Transl Med; 2024 May; 22(1):490. PubMed ID: 38790013
[TBL] [Abstract][Full Text] [Related]
17. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
Zheng H; Cao Z; Lv Y; Cai X
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
[TBL] [Abstract][Full Text] [Related]
18. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma.
Hu Y; Liu Y; Ma C; Ai K
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration.
Hu K; Yao L; Yan Y; Zhou L; Li J
Dis Markers; 2021; 2021():2789481. PubMed ID: 34497675
[TBL] [Abstract][Full Text] [Related]
20. YTHDF1 Promotes Cyclin B1 Translation through m
Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]